IDEXX Laboratories (IDXX)$559.37
Market Cap: 38.21 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for IDEXX Laboratories (IDXX).
HEALTHCARE
DIAGNOSTICS & RESEARCH
DCF ready
Valuation
36.4x
EV/FCF, 2.7% FCF yield
Quality
51.5%
ROIC, 24.6% FCF margin
Growth
9.7%
5Y sales (revenue) CAGR
Balance sheet
0.3x
Debt/equity, 1.2x current ratio
Superinvestors
6
Top: Terry Smith (6.4%)
Strengths to research
- Revenue compounded at 9.7% over five years.
- Free cash flow compounded at 14.3% over five years.
- Return on equity is strong at 66.0%.
- Free cash flow margin is healthy at 24.6%.
Watchouts
- P/E is elevated at 42.8x.
- P/FCF is elevated at 36.1x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for IDXX.
Grade B
76
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| IDXX Target | IDEXX Laboratories | $38.2B | 42.8x | 36.4x | 51.5% | 9.7% | 24.6% | 61.8% | 0.2x | N/A |
| A | Agilent Technologies | $30.9B | 25.2x | 27.9x | 13.3% | 5.4% | 16.6% | N/A | 0.7x | N/A |
| LZAGY | Lonza Group Ag Unspon ADR | $52.5B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| IQV | IQVIA Holdings Inc. | $26.9B | 21.4x | 12.1x | 20.9% | 7.5% | 12.6% | N/A | -0.6x | N/A |
| MTD | Mettler-Toledo International Inc. | $22.7B | 26.2x | 29.2x | 42.1% | 5.5% | 21.1% | 59.4% | N/A | N/A |
| NTRA | Natera Inc. | $21.4B | -133.7x | 186.2x | -12.2% | 42.6% | 4.7% | N/A | N/A | N/A |
| LH | Labcorp Holdings Inc. | $20.7B | 24.8x | 16.7x | 10.2% | -0.0% | 8.6% | 28.8% | -0.3x | N/A |
| DGX | Quest Diagnostics | $19.8B | 22.3x | 18.5x | 7.7% | 3.2% | 12.3% | N/A | 2.5x | N/A |
| ILMN | Illumina Inc. | $12.4B | 26.5x | 11.8x | 31.2% | 6.0% | 21.4% | 66.1% | -1.3x | N/A |
Financial Charts
No financial data available for IDXX (annual).
6 superinvestors own IDXX
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Terry Smith Fundsmith | 1,465,786 | $824M | 6.42% | 0.0% |
| Polen Capital Management Polen Capital Management | 695,811 | $391M | 2.70% | 0.0% |
| Wallace Weitz Weitz Large Cap Equity Fund | 35,300 | $20M | 1.38% | 0.0% |
| Jensen Investment Management Jensen Investment Management | 3,570 | $2M | 0.04% | 0.0% |
| Mairs & Power Growth Fund Mairs & Power Growth Fund | 2,080 | $1M | 0.01% | 0.0% |
| Bill Nygren Oakmark Select Fund | 482 | $271,000 | 0.00% | 0.0% |